Solventum Corp. (SOLV) Stock Analysis

Solventum Corp. (SOLV) is a publicly traded company in the HEALTHCARE sector. It trades at $75.84, carries a market capitalization of $13.13B, a price-to-earnings ratio of 9.28. This page summarizes the public market data, fundamentals, and frequently asked questions for SOLV, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NYSE

Key Metrics

• Price: $75.84
• Market Cap: $13.13B
• P/E Ratio: 9.28
• EPS: $8.17
• 52-Week High: $88.20
• 52-Week Low: $62.38

Market Sentiment

Solventum Corp. currently has a Neutral sentiment score of 0.07.

About Solventum Corp.

Solventum Corporation, based in Saint Paul, Minnesota, is a dynamic healthcare company focused on developing, manufacturing, and commercializing innovative solutions tailored to meet critical customer and patient needs. With a robust portfolio that spans various healthcare sectors, Solventum leverages cutting-edge research and technology to enhance patient outcomes and drive operational efficiency. The company's commitment to quality and excellence positions it as a key player in the healthca...

GNG Research Analysis

GNG Research scores Solventum Corp. (SOLV) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SOLV.

Frequently Asked Questions

Does SOLV pay dividends?

Solventum Corp. (SOLV) does not currently pay a regular dividend.

What is SOLV's P/E ratio?

Solventum Corp. has a price-to-earnings (P/E) ratio of 9.28.

What is SOLV's market cap?

Solventum Corp. (SOLV) has a market capitalization of $13.13B with a current stock price of $75.84.